1 Market Overview

1.1 Product Overview and Scope of Cell-Based Immunotherapy

1.2 Classification of Cell-Based Immunotherapy by Type

1.2.1 Overview: Global Cell-Based Immunotherapy Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Cell-Based Immunotherapy Revenue Market Share by Type in 2020

1.2.3 Autologous Cellular Immunotherapy

1.2.4 Chimeric Antigen Receptor (CAR) T-Cell Therapy

1.2.5 Dendritic Cell-based Vaccine Therapy

1.3 Global Cell-Based Immunotherapy Market by Application

1.3.1 Overview: Global Cell-Based Immunotherapy Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Ambulatory Surgical Centers

1.3.5 Others

1.4 Global Cell-Based Immunotherapy Market Size & Forecast

1.5 Global Cell-Based Immunotherapy Market Size and Forecast by Region

1.5.1 Global Cell-Based Immunotherapy Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Cell-Based Immunotherapy Market Size by Region, (2016-2021)

1.5.3 North America Cell-Based Immunotherapy Market Size and Prospect (2016-2026)

1.5.4 Europe Cell-Based Immunotherapy Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Cell-Based Immunotherapy Market Size and Prospect (2016-2026)

1.5.6 South America Cell-Based Immunotherapy Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Cell-Based Immunotherapy Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Cell-Based Immunotherapy Market Drivers

1.6.2 Cell-Based Immunotherapy Market Restraints

1.6.3 Cell-Based Immunotherapy Trends Analysis

2 Company Profiles

2.1 Novartis

2.1.1 Novartis Details

2.1.2 Novartis Major Business

2.1.3 Novartis Cell-Based Immunotherapy Product and Solutions

2.1.4 Novartis Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Novartis Recent Developments and Future Plans

2.2 Gilead Sciences

2.2.1 Gilead Sciences Details

2.2.2 Gilead Sciences Major Business

2.2.3 Gilead Sciences Cell-Based Immunotherapy Product and Solutions

2.2.4 Gilead Sciences Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Gilead Sciences Recent Developments and Future Plans

2.3 AbbVie

2.3.1 AbbVie Details

2.3.2 AbbVie Major Business

2.3.3 AbbVie Cell-Based Immunotherapy Product and Solutions

2.3.4 AbbVie Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 AbbVie Recent Developments and Future Plans

2.4 Bristol-Myers Squibb

2.4.1 Bristol-Myers Squibb Details

2.4.2 Bristol-Myers Squibb Major Business

2.4.3 Bristol-Myers Squibb Cell-Based Immunotherapy Product and Solutions

2.4.4 Bristol-Myers Squibb Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.5 Amgen

2.5.1 Amgen Details

2.5.2 Amgen Major Business

2.5.3 Amgen Cell-Based Immunotherapy Product and Solutions

2.5.4 Amgen Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Amgen Recent Developments and Future Plans

2.6 AstraZeneca

2.6.1 AstraZeneca Details

2.6.2 AstraZeneca Major Business

2.6.3 AstraZeneca Cell-Based Immunotherapy Product and Solutions

2.6.4 AstraZeneca Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 AstraZeneca Recent Developments and Future Plans

2.7 Biogen

2.7.1 Biogen Details

2.7.2 Biogen Major Business

2.7.3 Biogen Cell-Based Immunotherapy Product and Solutions

2.7.4 Biogen Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Biogen Recent Developments and Future Plans

2.8 Boehringer Ingelheim

2.8.1 Boehringer Ingelheim Details

2.8.2 Boehringer Ingelheim Major Business

2.8.3 Boehringer Ingelheim Cell-Based Immunotherapy Product and Solutions

2.8.4 Boehringer Ingelheim Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Boehringer Ingelheim Recent Developments and Future Plans

2.9 Eli Lilly and Company

2.9.1 Eli Lilly and Company Details

2.9.2 Eli Lilly and Company Major Business

2.9.3 Eli Lilly and Company Cell-Based Immunotherapy Product and Solutions

2.9.4 Eli Lilly and Company Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Eli Lilly and Company Recent Developments and Future Plans

2.10 GSK

2.10.1 GSK Details

2.10.2 GSK Major Business

2.10.3 GSK Cell-Based Immunotherapy Product and Solutions

2.10.4 GSK Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 GSK Recent Developments and Future Plans

2.11 Pfizer

2.11.1 Pfizer Details

2.11.2 Pfizer Major Business

2.11.3 Pfizer Cell-Based Immunotherapy Product and Solutions

2.11.4 Pfizer Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Pfizer Recent Developments and Future Plans

2.12 Roche

2.12.1 Roche Details

2.12.2 Roche Major Business

2.12.3 Roche Cell-Based Immunotherapy Product and Solutions

2.12.4 Roche Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Roche Recent Developments and Future Plans

2.13 Takara Bio

2.13.1 Takara Bio Details

2.13.2 Takara Bio Major Business

2.13.3 Takara Bio Cell-Based Immunotherapy Product and Solutions

2.13.4 Takara Bio Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Takara Bio Recent Developments and Future Plans

2.14 Bausch Health

2.14.1 Bausch Health Details

2.14.2 Bausch Health Major Business

2.14.3 Bausch Health Cell-Based Immunotherapy Product and Solutions

2.14.4 Bausch Health Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Bausch Health Recent Developments and Future Plans

2.15 Apac Biotech

2.15.1 Apac Biotech Details

2.15.2 Apac Biotech Major Business

2.15.3 Apac Biotech Cell-Based Immunotherapy Product and Solutions

2.15.4 Apac Biotech Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Apac Biotech Recent Developments and Future Plans

2.16 Dendreon Pharmaceuticals (SanPower)

2.16.1 Dendreon Pharmaceuticals (SanPower) Details

2.16.2 Dendreon Pharmaceuticals (SanPower) Major Business

2.16.3 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product and Solutions

2.16.4 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Dendreon Pharmaceuticals (SanPower) Recent Developments and Future Plans

2.17 JW CreaGene

2.17.1 JW CreaGene Details

2.17.2 JW CreaGene Major Business

2.17.3 JW CreaGene Cell-Based Immunotherapy Product and Solutions

2.17.4 JW CreaGene Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 JW CreaGene Recent Developments and Future Plans

2.18 Green Cross Corp

2.18.1 Green Cross Corp Details

2.18.2 Green Cross Corp Major Business

2.18.3 Green Cross Corp Cell-Based Immunotherapy Product and Solutions

2.18.4 Green Cross Corp Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Green Cross Corp Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Cell-Based Immunotherapy Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Cell-Based Immunotherapy Players Market Share

3.2.2 Top 10 Cell-Based Immunotherapy Players Market Share

3.2.3 Market Competition Trend

3.3 Cell-Based Immunotherapy Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Cell-Based Immunotherapy Revenue and Market Share by Type (2016-2021)

4.2 Global Cell-Based Immunotherapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Cell-Based Immunotherapy Revenue Market Share by Application (2016-2021)

5.2 Cell-Based Immunotherapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Cell-Based Immunotherapy Revenue by Type (2016-2026)

6.2 North America Cell-Based Immunotherapy Revenue by Application (2016-2026)

6.3 North America Cell-Based Immunotherapy Market Size by Country

6.3.1 North America Cell-Based Immunotherapy Revenue by Country (2016-2026)

6.3.2 United States Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

6.3.3 Canada Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

6.3.4 Mexico Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Cell-Based Immunotherapy Revenue by Type (2016-2026)

7.2 Europe Cell-Based Immunotherapy Revenue by Application (2016-2026)

7.3 Europe Cell-Based Immunotherapy Market Size by Country

7.3.1 Europe Cell-Based Immunotherapy Revenue by Country (2016-2026)

7.3.2 Germany Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

7.3.3 France Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

7.3.5 Russia Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

7.3.6 Italy Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Cell-Based Immunotherapy Revenue by Type (2016-2026)

8.2 Asia-Pacific Cell-Based Immunotherapy Revenue by Application (2016-2026)

8.3 Asia-Pacific Cell-Based Immunotherapy Market Size by Region

8.3.1 Asia-Pacific Cell-Based Immunotherapy Revenue by Region (2016-2026)

8.3.2 China Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

8.3.3 Japan Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

8.3.4 South Korea Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

8.3.5 India Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

8.3.7 Australia Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Cell-Based Immunotherapy Revenue by Type (2016-2026)

9.2 South America Cell-Based Immunotherapy Revenue by Application (2016-2026)

9.3 South America Cell-Based Immunotherapy Market Size by Country

9.3.1 South America Cell-Based Immunotherapy Revenue by Country (2016-2026)

9.3.2 Brazil Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

9.3.3 Argentina Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Cell-Based Immunotherapy Revenue by Type (2016-2026)

10.2 Middle East & Africa Cell-Based Immunotherapy Revenue by Application (2016-2026)

10.3 Middle East & Africa Cell-Based Immunotherapy Market Size by Country

10.3.1 Middle East & Africa Cell-Based Immunotherapy Revenue by Country (2016-2026)

10.3.2 Turkey Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

10.3.4 UAE Cell-Based Immunotherapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Cell-Based Immunotherapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Cell-Based Immunotherapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Cell-Based Immunotherapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Cell-Based Immunotherapy Revenue (USD Million) by Region (2016-2021)

Table 5. Global Cell-Based Immunotherapy Revenue Market Share by Region (2021-2026)

Table 6. Novartis Corporate Information, Head Office, and Major Competitors

Table 7. Novartis Major Business

Table 8. Novartis Cell-Based Immunotherapy Product and Solutions

Table 9. Novartis Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Gilead Sciences Corporate Information, Head Office, and Major Competitors

Table 11. Gilead Sciences Major Business

Table 12. Gilead Sciences Cell-Based Immunotherapy Product and Solutions

Table 13. Gilead Sciences Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. AbbVie Corporate Information, Head Office, and Major Competitors

Table 15. AbbVie Major Business

Table 16. AbbVie Cell-Based Immunotherapy Product and Solutions

Table 17. AbbVie Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 19. Bristol-Myers Squibb Major Business

Table 20. Bristol-Myers Squibb Cell-Based Immunotherapy Product and Solutions

Table 21. Bristol-Myers Squibb Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Amgen Corporate Information, Head Office, and Major Competitors

Table 23. Amgen Major Business

Table 24. Amgen Cell-Based Immunotherapy Product and Solutions

Table 25. Amgen Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 27. AstraZeneca Major Business

Table 28. AstraZeneca Cell-Based Immunotherapy Product and Solutions

Table 29. AstraZeneca Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Biogen Corporate Information, Head Office, and Major Competitors

Table 31. Biogen Major Business

Table 32. Biogen Cell-Based Immunotherapy Product and Solutions

Table 33. Biogen Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors

Table 35. Boehringer Ingelheim Major Business

Table 36. Boehringer Ingelheim Cell-Based Immunotherapy Product and Solutions

Table 37. Boehringer Ingelheim Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors

Table 39. Eli Lilly and Company Major Business

Table 40. Eli Lilly and Company Cell-Based Immunotherapy Product and Solutions

Table 41. Eli Lilly and Company Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. GSK Corporate Information, Head Office, and Major Competitors

Table 43. GSK Major Business

Table 44. GSK Cell-Based Immunotherapy Product and Solutions

Table 45. GSK Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Pfizer Corporate Information, Head Office, and Major Competitors

Table 47. Pfizer Major Business

Table 48. Pfizer Cell-Based Immunotherapy Product and Solutions

Table 49. Pfizer Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Roche Corporate Information, Head Office, and Major Competitors

Table 51. Roche Major Business

Table 52. Roche Cell-Based Immunotherapy Product and Solutions

Table 53. Roche Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Takara Bio Corporate Information, Head Office, and Major Competitors

Table 55. Takara Bio Major Business

Table 56. Takara Bio Cell-Based Immunotherapy Product and Solutions

Table 57. Takara Bio Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Bausch Health Corporate Information, Head Office, and Major Competitors

Table 59. Bausch Health Major Business

Table 60. Bausch Health Cell-Based Immunotherapy Product and Solutions

Table 61. Bausch Health Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Apac Biotech Corporate Information, Head Office, and Major Competitors

Table 63. Apac Biotech Major Business

Table 64. Apac Biotech Cell-Based Immunotherapy Product and Solutions

Table 65. Apac Biotech Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Dendreon Pharmaceuticals (SanPower) Corporate Information, Head Office, and Major Competitors

Table 67. Dendreon Pharmaceuticals (SanPower) Major Business

Table 68. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product and Solutions

Table 69. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. JW CreaGene Corporate Information, Head Office, and Major Competitors

Table 71. JW CreaGene Major Business

Table 72. JW CreaGene Cell-Based Immunotherapy Product and Solutions

Table 73. JW CreaGene Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Green Cross Corp Corporate Information, Head Office, and Major Competitors

Table 75. Green Cross Corp Major Business

Table 76. Green Cross Corp Cell-Based Immunotherapy Product and Solutions

Table 77. Green Cross Corp Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Global Cell-Based Immunotherapy Revenue (USD Million) by Players (2019-2021)

Table 79. Global Cell-Based Immunotherapy Revenue Share by Players (2019-2021)

Table 80. Breakdown of Cell-Based Immunotherapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 81. Cell-Based Immunotherapy Players Head Office, Products and Services Provided

Table 82. Cell-Based Immunotherapy Mergers & Acquisitions in the Past Five Years

Table 83. Cell-Based Immunotherapy New Entrants and Expansion Plans

Table 84. Global Cell-Based Immunotherapy Revenue (USD Million) by Type (2016-2021)

Table 85. Global Cell-Based Immunotherapy Revenue Share by Type (2016-2021)

Table 86. Global Cell-Based Immunotherapy Revenue Forecast by Type (2021-2026)

Table 87. Global Cell-Based Immunotherapy Revenue by Application (2016-2021)

Table 88. Global Cell-Based Immunotherapy Revenue Forecast by Application (2021-2026)

Table 89. North America Cell-Based Immunotherapy Revenue by Type (2016-2021) & (USD Million)

Table 90. North America Cell-Based Immunotherapy Revenue by Type (2021-2026) & (USD Million)

Table 91. North America Cell-Based Immunotherapy Revenue by Application (2016-2021) & (USD Million)

Table 92. North America Cell-Based Immunotherapy Revenue by Application (2021-2026) & (USD Million)

Table 93. North America Cell-Based Immunotherapy Revenue by Country (2016-2021) & (USD Million)

Table 94. North America Cell-Based Immunotherapy Revenue by Country (2021-2026) & (USD Million)

Table 95. Europe Cell-Based Immunotherapy Revenue by Type (2016-2021) & (USD Million)

Table 96. Europe Cell-Based Immunotherapy Revenue by Type (2021-2026) & (USD Million)

Table 97. Europe Cell-Based Immunotherapy Revenue by Application (2016-2021) & (USD Million)

Table 98. Europe Cell-Based Immunotherapy Revenue by Application (2021-2026) & (USD Million)

Table 99. Europe Cell-Based Immunotherapy Revenue by Country (2016-2021) & (USD Million)

Table 100. Europe Cell-Based Immunotherapy Revenue by Country (2021-2026) & (USD Million)

Table 101. Asia-Pacific Cell-Based Immunotherapy Revenue by Type (2016-2021) & (USD Million)

Table 102. Asia-Pacific Cell-Based Immunotherapy Revenue by Type (2021-2026) & (USD Million)

Table 103. Asia-Pacific Cell-Based Immunotherapy Revenue by Application (2016-2021) & (USD Million)

Table 104. Asia-Pacific Cell-Based Immunotherapy Revenue by Application (2021-2026) & (USD Million)

Table 105. Asia-Pacific Cell-Based Immunotherapy Revenue by Region (2016-2021) & (USD Million)

Table 106. Asia-Pacific Cell-Based Immunotherapy Revenue by Region (2021-2026) & (USD Million)

Table 107. South America Cell-Based Immunotherapy Revenue by Type (2016-2021) & (USD Million)

Table 108. South America Cell-Based Immunotherapy Revenue by Type (2021-2026) & (USD Million)

Table 109. South America Cell-Based Immunotherapy Revenue by Application (2016-2021) & (USD Million)

Table 110. South America Cell-Based Immunotherapy Revenue by Application (2021-2026) & (USD Million)

Table 111. South America Cell-Based Immunotherapy Revenue by Country (2016-2021) & (USD Million)

Table 112. South America Cell-Based Immunotherapy Revenue by Country (2021-2026) & (USD Million)

Table 113. Middle East & Africa Cell-Based Immunotherapy Revenue by Type (2016-2021) & (USD Million)

Table 114. Middle East & Africa Cell-Based Immunotherapy Revenue by Type (2021-2026) & (USD Million)

Table 115. Middle East & Africa Cell-Based Immunotherapy Revenue by Application (2016-2021) & (USD Million)

Table 116. Middle East & Africa Cell-Based Immunotherapy Revenue by Application (2021-2026) & (USD Million)

Table 117. Middle East & Africa Cell-Based Immunotherapy Revenue by Country (2016-2021) & (USD Million)

Table 118. Middle East & Africa Cell-Based Immunotherapy Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Cell-Based Immunotherapy Picture

Figure 2. Global Cell-Based Immunotherapy Revenue Market Share by Type in 2020

Figure 3. Autologous Cellular Immunotherapy

Figure 4. Chimeric Antigen Receptor (CAR) T-Cell Therapy

Figure 5. Dendritic Cell-based Vaccine Therapy

Figure 6. Cell-Based Immunotherapy Revenue Market Share by Application in 2020

Figure 7. Hospitals Picture

Figure 8. Clinics Picture

Figure 9. Ambulatory Surgical Centers Picture

Figure 10. Others Picture

Figure 11. Global Cell-Based Immunotherapy Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 12. Global Cell-Based Immunotherapy Revenue and Forecast (2016-2026) & (USD Million)

Figure 13. Global Cell-Based Immunotherapy Revenue Market Share by Region (2016-2026)

Figure 14. Global Cell-Based Immunotherapy Revenue Market Share by Region in 2020

Figure 15. North America Cell-Based Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Europe Cell-Based Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Asia-Pacific Cell-Based Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. South America Cell-Based Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Middle East and Africa Cell-Based Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Cell-Based Immunotherapy Market Drivers

Figure 21. Cell-Based Immunotherapy Market Restraints

Figure 22. Cell-Based Immunotherapy Market Trends

Figure 23. Novartis Recent Developments and Future Plans

Figure 24. Gilead Sciences Recent Developments and Future Plans

Figure 25. AbbVie Recent Developments and Future Plans

Figure 26. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 27. Amgen Recent Developments and Future Plans

Figure 28. AstraZeneca Recent Developments and Future Plans

Figure 29. Biogen Recent Developments and Future Plans

Figure 30. Boehringer Ingelheim Recent Developments and Future Plans

Figure 31. Eli Lilly and Company Recent Developments and Future Plans

Figure 32. GSK Recent Developments and Future Plans

Figure 33. Pfizer Recent Developments and Future Plans

Figure 34. Roche Recent Developments and Future Plans

Figure 35. Takara Bio Recent Developments and Future Plans

Figure 36. Bausch Health Recent Developments and Future Plans

Figure 37. Apac Biotech Recent Developments and Future Plans

Figure 38. Dendreon Pharmaceuticals (SanPower) Recent Developments and Future Plans

Figure 39. JW CreaGene Recent Developments and Future Plans

Figure 40. Green Cross Corp Recent Developments and Future Plans

Figure 41. Global Cell-Based Immunotherapy Revenue Share by Players in 2020

Figure 42. Cell-Based Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 43. Global Top 3 Players Cell-Based Immunotherapy Revenue Market Share in 2020

Figure 44. Global Top 10 Players Cell-Based Immunotherapy Revenue Market Share in 2020

Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 46. Global Cell-Based Immunotherapy Revenue Share by Type in 2020

Figure 47. Global Cell-Based Immunotherapy Market Share Forecast by Type (2021-2026)

Figure 48. Global Cell-Based Immunotherapy Revenue Share by Application in 2020

Figure 49. Global Cell-Based Immunotherapy Market Share Forecast by Application (2021-2026)

Figure 50. North America Cell-Based Immunotherapy Sales Market Share by Type (2016-2026)

Figure 51. North America Cell-Based Immunotherapy Sales Market Share by Application (2016-2026)

Figure 52. North America Cell-Based Immunotherapy Revenue Market Share by Country (2016-2026)

Figure 53. United States Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Canada Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Mexico Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Europe Cell-Based Immunotherapy Sales Market Share by Type (2016-2026)

Figure 57. Europe Cell-Based Immunotherapy Sales Market Share by Application (2016-2026)

Figure 58. Europe Cell-Based Immunotherapy Revenue Market Share by Country (2016-2026)

Figure 59. Germany Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. France Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. United Kingdom Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Russia Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Italy Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Asia-Pacific Cell-Based Immunotherapy Sales Market Share by Type (2016-2026)

Figure 65. Asia-Pacific Cell-Based Immunotherapy Sales Market Share by Application (2016-2026)

Figure 66. Asia-Pacific Cell-Based Immunotherapy Revenue Market Share by Region (2016-2026)

Figure 67. China Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Japan Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. South Korea Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. India Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Southeast Asia Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Australia Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. South America Cell-Based Immunotherapy Sales Market Share by Type (2016-2026)

Figure 74. South America Cell-Based Immunotherapy Sales Market Share by Application (2016-2026)

Figure 75. South America Cell-Based Immunotherapy Revenue Market Share by Country (2016-2026)

Figure 76. Brazil Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Argentina Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Middle East and Africa Cell-Based Immunotherapy Sales Market Share by Type (2016-2026)

Figure 79. Middle East and Africa Cell-Based Immunotherapy Sales Market Share by Application (2016-2026)

Figure 80. Middle East and Africa Cell-Based Immunotherapy Revenue Market Share by Country (2016-2026)

Figure 81. Turkey Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Saudi Arabia Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. UAE Cell-Based Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. Methodology

Figure 85. Research Process and Data Source